NO20011634D0 - Krystall av diuridintetrafosfat eller salter derav, og fremgangsmåte for fremstilling av samme og fremgangsmåte for fremstilling av nevnte forbindelse - Google Patents

Krystall av diuridintetrafosfat eller salter derav, og fremgangsmåte for fremstilling av samme og fremgangsmåte for fremstilling av nevnte forbindelse

Info

Publication number
NO20011634D0
NO20011634D0 NO20011634A NO20011634A NO20011634D0 NO 20011634 D0 NO20011634 D0 NO 20011634D0 NO 20011634 A NO20011634 A NO 20011634A NO 20011634 A NO20011634 A NO 20011634A NO 20011634 D0 NO20011634 D0 NO 20011634D0
Authority
NO
Norway
Prior art keywords
salt
ump
crystals
preparation
ppi
Prior art date
Application number
NO20011634A
Other languages
English (en)
Other versions
NO20011634L (no
NO317305B1 (no
Inventor
Hideaki Maeda
Toshio Yamada
Hiroshi Sato
Yutaka Noda
Original Assignee
Yamasa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corp filed Critical Yamasa Corp
Publication of NO20011634D0 publication Critical patent/NO20011634D0/no
Publication of NO20011634L publication Critical patent/NO20011634L/no
Publication of NO317305B1 publication Critical patent/NO317305B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20011634A 1998-10-02 2001-03-30 Krystall av diuridintetrafosfat eller salter derav, og fremgangsmate for fremstilling av samme og fremgangsmate for fremstilling av nevnte forbindelse NO317305B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28166398 1998-10-02
JP17068199 1999-06-17
PCT/JP1999/005415 WO2000020430A1 (fr) 1998-10-02 1999-10-01 Cristal de diuridine tetraphosphate ou sel correspondant et procede de fabrication

Publications (3)

Publication Number Publication Date
NO20011634D0 true NO20011634D0 (no) 2001-03-30
NO20011634L NO20011634L (no) 2001-05-30
NO317305B1 NO317305B1 (no) 2004-10-04

Family

ID=26493605

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011634A NO317305B1 (no) 1998-10-02 2001-03-30 Krystall av diuridintetrafosfat eller salter derav, og fremgangsmate for fremstilling av samme og fremgangsmate for fremstilling av nevnte forbindelse

Country Status (21)

Country Link
US (2) US6458946B1 (no)
EP (1) EP1043329B1 (no)
JP (2) JP3247685B2 (no)
KR (1) KR100475008B1 (no)
CN (2) CN100396692C (no)
AT (1) ATE222920T1 (no)
AU (1) AU747096C (no)
BR (2) BRPI9917911B1 (no)
CA (1) CA2345624C (no)
CZ (1) CZ300402B6 (no)
DE (1) DE69902624T2 (no)
EA (2) EA003167B1 (no)
ES (1) ES2183650T3 (no)
HU (1) HU228681B1 (no)
IL (1) IL142181A (no)
MX (1) MXPA01003377A (no)
NO (1) NO317305B1 (no)
NZ (1) NZ510748A (no)
PL (1) PL199434B1 (no)
SK (1) SK283729B6 (no)
WO (1) WO2000020430A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223744B2 (en) 1997-02-10 2007-05-29 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
US7078391B2 (en) 1997-02-10 2006-07-18 Inspire Pharmaceuticals, Inc. Method of treating edematous retinal disorders
US6818629B2 (en) 1997-02-10 2004-11-16 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
US6872710B2 (en) 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
AU767136B2 (en) * 1999-06-30 2003-10-30 Merck Sharp & Dohme Corp. Dinucleotide crystals
US6867199B2 (en) 2000-08-21 2005-03-15 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapeutic use
CN100363376C (zh) * 2006-06-12 2008-01-23 南京工业大学 一种5’-核苷三磷酸钠盐的结晶方法
CN107709345A (zh) * 2015-06-29 2018-02-16 雅玛山酱油株式会社 P1，p4‑二(尿苷5′）‑四磷酸晶体的保存方法
WO2018079503A1 (ja) 2016-10-25 2018-05-03 ヤマサ醤油株式会社 Ｐ１，ｐ４－ジ（ウリジン５'－）テトラホスフェートの精製方法
KR20180091689A (ko) * 2017-11-06 2018-08-16 주식회사 종근당 무정형 디뉴클레오사이드 폴리포스페이트 화합물의 제조방법
CN109021049B (zh) * 2018-06-14 2020-12-08 扬子江药业集团北京海燕药业有限公司 一种尿苷5′-二磷酸-苯并咪唑二钠的合成方法
KR20210110055A (ko) * 2020-02-28 2021-09-07 주식회사 종근당바이오 P1, p4-디(우리딘 5'-)테트라포스페이트 나트륨염 4 수화물 결정형 a의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423694B1 (en) * 1996-02-21 2002-07-23 Inspire Pharmaceuticals, Inc. Method of treating otitis media with uridine triphosphates and related compounds
CN1229114C (zh) * 1996-03-27 2005-11-30 印斯拜尔药品股份有限公司 用三磷酸尿苷和相关化合物治疗纤毛运动障碍的方法
US6319908B1 (en) * 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5763447C1 (en) * 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
NZ501696A (en) * 1997-07-25 2001-08-31 Inspire Pharmaceuticals Inc Method for large-scale production of sodium and ammonium salts of di(uridine 5')-tetraphosphate

Also Published As

Publication number Publication date
US20020156269A1 (en) 2002-10-24
MXPA01003377A (es) 2003-06-24
IL142181A (en) 2005-12-18
EA200200695A1 (ru) 2002-10-31
IL142181A0 (en) 2002-03-10
NO20011634L (no) 2001-05-30
JP3824894B2 (ja) 2006-09-20
CZ20011028A3 (cs) 2001-08-15
CN1502622A (zh) 2004-06-09
US6780988B2 (en) 2004-08-24
SK4402001A3 (en) 2001-11-06
NZ510748A (en) 2002-10-25
AU6000899A (en) 2000-04-26
EP1043329B1 (en) 2002-08-28
JP2002053590A (ja) 2002-02-19
NO317305B1 (no) 2004-10-04
CA2345624A1 (en) 2000-04-13
HU228681B1 (en) 2013-05-28
ES2183650T3 (es) 2003-03-16
CA2345624C (en) 2006-12-05
EA003167B1 (ru) 2003-02-27
BRPI9917911B1 (pt) 2016-08-23
EA004513B1 (ru) 2004-04-29
EP1043329A4 (en) 2001-03-14
CZ300402B6 (cs) 2009-05-13
CN1151166C (zh) 2004-05-26
PL347070A1 (en) 2002-03-11
AU747096B2 (en) 2002-05-09
ATE222920T1 (de) 2002-09-15
CN100396692C (zh) 2008-06-25
EA200100407A1 (ru) 2001-10-22
DE69902624T2 (de) 2003-04-03
PL199434B1 (pl) 2008-09-30
KR100475008B1 (ko) 2005-03-08
US6458946B1 (en) 2002-10-01
DE69902624D1 (de) 2002-10-02
JP3247685B2 (ja) 2002-01-21
SK283729B6 (sk) 2003-12-02
CN1321163A (zh) 2001-11-07
WO2000020430A1 (fr) 2000-04-13
HUP0103754A2 (hu) 2002-04-29
AU747096C (en) 2003-01-23
BR9914453A (pt) 2001-05-22
KR20020013471A (ko) 2002-02-20
HUP0103754A3 (en) 2003-01-28
EP1043329A1 (en) 2000-10-11

Similar Documents

Publication Publication Date Title
NO20011634D0 (no) Krystall av diuridintetrafosfat eller salter derav, og fremgangsmåte for fremstilling av samme og fremgangsmåte for fremstilling av nevnte forbindelse
BG105547A (en) Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
NO893947D0 (no) Bornitrogenpolymerer og fremgangsmaate for deres fremstilling.
WO2001016151A1 (fr) Acide nucleique a photocouplage reversible et phosphoroamidite
ATE300551T1 (de) Dinukleotid-kristalle
RU94046317A (ru) Новое синтетическое промежуточное соединение для получения производных и способы получения производных аминокислот
EP1460065A4 (en) METHOD FOR THE PRODUCTION OF CYCLIC DIAMINO COMPOUNDS BZW. THE SALTS
RU95108553A (ru) Способ получения нуклеозидных аналогов с использованием бициклических промежуточных продуктов
WO2001096278A3 (en) A novel process for preparing salmeterol
JPH08268995A (ja) アミノアルキルスルホン酸類の製造方法
FI87764B (fi) Foerfarande foer framstaellning av peracetylerade sockeralkoholer fraon sockeralkoholer, vilka har minst 4 kolatomer
JP2624840B2 (ja) 光学活性なアミド化合物の製法
ES2191282T3 (es) Procedimiento para purificar trihidrocarbilfosfinas usando metanol.
CA2361565A1 (en) Synthesis of ethyleneimine dimer
IL166696A0 (en) A process for producing y-ketoacetal compounds
HUP0401401A2 (hu) Eljárás 7-kinolinil-3,5-dihidroxi-hept-6-enoát előállítására
Takeuchi et al. Stereospecific addition of singlet phenylnitrenium ion to some alkenes. Reactions of phenyl azide with alkenes in the presence of trifluoroacetic acid
EP1035114A3 (en) Nitrogen-heterocyclic compounds and process for production thereof
YU25099A (sh) Postupak za sintezu 1,4-dihidropiridinskih derivata
JPS63203673A (ja) Ｄｌ−パントラクトンの光学分割法
JPS637557B2 (no)
LV12664A (lv) Synthesis of 4-substituted 2-oxobutenic acid sodium salts
JP2005187441A (ja) Ｎ−グリコシルアミドの製造方法
JPH0616614A (ja) ニトリルの製造法

Legal Events

Date Code Title Description
MK1K Patent expired